the relevance of sct in multiple myeloma
Published 2 years ago • 138 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
2:06
an insight into the sequencing of car-t and bispecifics in myeloma
-
1:13
using integrative multiomics to explain myeloma progression and evolution of refractory disease
-
5:17
the evolving role of autologous transplantation in multiple myeloma
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
0:59
defining the origins of multiple myeloma
-
5:00
rouleaux formation | peripheral blood smear examination | hematology | multiple myeloma| esr |
-
7:25
multiple myeloma stem cell transplant
-
3:02
myeloma uk autologous stem cell transplantation
-
2:13
the impact of mrd in apheresis product in patients with myeloma undergoing autosct
-
1:50
molecular characteristics of extramedullary myeloma
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
3:05
recent advances in newly diagnosed multiple myeloma and the importance of patient perspectives
-
1:53
transplantation for consolidation in multiple myeloma
-
1:59
the role of upfront double auto-sct in high-risk myeloma
-
1:38
the current and future management of myeloma in the second-line
-
3:32
potential applications of artificial intelligence in myeloma
-
2:25
pre-clinical activity of ucartcs1 in multiple myeloma
-
1:48
the role of autologous transplantation in young and fit patients with multiple myeloma in 2022
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
4:10
the role of alc and early crs in predicting delayed responses to teclistamab in myeloma
-
1:53
the future of multiple myeloma treatment
-
2:52
the role of the bnip1 gene in familial myeloma